EyeCare Partners Credit Rating & NNN Cap Rate

EyeCare Partners credit rating, NNN cap rate, and investment grade tenant profile
MetricDetails
Entity / Legal NameEyeCare Partners, LLC
OwnershipWarburg Pincus (PE) — recapitalized 2023
S&P / Moody’s RatingCCC+ / Caa2 (highly leveraged PE recapitalization)
Investment Grade StatusNon-Investment Grade — Substantial Risk
SectorOptometry / Vision Care DSO
US Location Count750+
Cap Rate Range7.50–9.00%
Typical Lease Term5–10 years (NNN)
Guarantee TypeEyeCare Partners corporate entity
Annual Revenue~$1.1B (est., FY2024)
Typical Building Size2,500–4,500 SF
Typical Price Range$1,500,000–$3,500,000

EyeCare Partners Business Overview & NNN Investment Profile

EyeCare Partners is one of the largest optometry and ophthalmology practice management companies in the United States, operating over 750 vision care clinic locations across 18+ states under multiple regional brand names. The Maryland Heights, Missouri-based DSO (Dental Service Organization equivalent in vision care) provides management services to affiliated optometry and ophthalmology practices, consolidating the historically fragmented independent optometry market under a PE-backed roll-up structure. EyeCare Partners was originally backed by FFL Partners and later recapitalized with Warburg Pincus taking the majority position in 2023 through a debt restructuring that significantly impacted the company’s credit profile.

Non-Investment Grade — Substantial Risk: CCC+/Caa2. EyeCare Partners carries CCC+/Caa2 ratings reflecting the significant leverage burden from its PE-era capital structure and the 2023 debt restructuring. The CCC+/Caa2 tier indicates the company is vulnerable to default absent favorable business conditions — the highest credit risk tier among the healthcare NNN tenants profiled on this page. NNN investors evaluating EyeCare Partners properties must weigh the meaningful cap rate premium against the elevated default risk. Strong individual location performance and essential vision care services are positives; the holding company capital structure is the constraint.

EyeCare Partners vs. MyEyeDr: Two Vision Care DSOs Compared

Two major optometry DSOs generate NNN transaction volume in the US market. EyeCare Partners (CCC+/Caa2) and MyEyeDr (NR/B3) both operate 700+ locations and occupy similar suburban retail corridors. EyeCare Partners’ deeper credit impairment (CCC+ vs. MyEyeDr’s approximate B3 equivalent) typically commands wider cap rates in the market, with investors requiring a 50 to 100 basis point premium for the additional default risk. Location analysis — market demographics, competition from LensCrafters and Walmart Vision, lease term remaining — becomes even more critical at the CCC tier.

EyeCare Partners NNN Lease Structure & Cap Rates

EyeCare Partners NNN leases carry 5 to 10 year initial terms — shorter than dental DSOs — with annual escalations of 2% to 3%. The 2,500 to 4,500 SF inline strip center and power center format is highly accessible and re-tenantable to competing vision or medical uses. Cap rates for EyeCare Partners NNN properties trade between 7.50% and 9.00% as of Q1 2026. The CCC+/Caa2 rating and shorter lease terms command wide spreads. Suburban locations in strong demographic trade areas with long remaining lease terms price closer to 7.50%. Shorter-term assets and secondary markets price above 8.50%.

Is EyeCare Partners investment grade?

No. EyeCare Partners carries CCC+ from S&P and Caa2 from Moody’s following the 2023 PE debt restructuring — the highest credit risk tier. NNN investors should require a significant cap rate premium and conduct thorough location-level due diligence before committing.

What cap rates are EyeCare Partners NNN properties trading at?

EyeCare Partners NNN properties trade at 7.50% to 9.00% as of Q1 2026. The CCC+/Caa2 credit and shorter 5 to 10 year lease terms command wide spreads. Acquisition prices range from $1,500,000 to $3,500,000.

The Only EyeCare Partners NNN Advisor Whose Fee Comes From the Deal, Not From You

In NNN buyer representation, the listing broker pays the cooperating commission.

Find It — We evaluate location demographics, lease term, and re-tenanting viability before you commit due diligence costs on CCC-rated credit.

Exit It / 1031 — Looking to step up from EyeCare Partners to investment-grade healthcare NNN? We source replacement assets and manage the full 1031 timeline.

Talk to a Healthcare NNN Specialist →

In a 1031 exchange? Tell us your timeline — we move faster.

Related NNN Tenants

Own a EyeCare Partners Property? Capital Markets Strategies Beyond Selling

Maturing debt and considering refinancing? Our capital markets team maintains 150+ lender relationships underwriting NNN properties across investment-grade and non-investment-grade credit tiers. We structure rate-and-term refinancing, cash-out refis, and bridge-to-perm takeouts.

Evaluating a 1031 exchange or disposition? We represent both sides of EyeCare Partners NNN transactions — whether you are looking to exit at peak value, exchange into a higher-quality credit tenant, or reposition within the same sector.

Need a current valuation? We maintain live comps on EyeCare Partners NNN transactions and can produce a Broker Opinion of Value within 48 hours reflecting today’s cap rate market.

Schedule a 15-minute capital markets consultation →

Own multiple EyeCare Partners properties? Considering an off-market sale?

Investment Grade represents owners on confidential disposition of EyeCare Partners portfolios and individual properties through off-market direct-to-principal distribution to specialty REITs, private equity funds, and family offices. EyeCare Partners buyer demand runs deep, and portfolio sales consistently produce stronger pricing than sequential individual sales because the institutional buyer pool is structured around portfolio acquisition.

For multi-property owners considering a portfolio disposition, see Selling Investment Grade NNN Off-Market: Tenant-by-Tenant Buyer Demand. For the full off-market framework covering individual property dispositions, sale-leasebacks, and 1031 coordination, see Off-Market CRE Sales: The Complete 2026 Guide.

The pre-listing conversation is at no cost and fully confidential. Email team@investmentgrade.com or see contact Investment Grade.

Real Estate

Capital

Making the Grade